Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, unique proteins that regulate vital biological functions that are impaired in various disease states. Targacept’s clinical pipeline includes multiple Phase 2 product candidates, all representing first-in-class opportunities. Targacept leverages its scientific leadership and diverse pipeline to attract significant collaborations with global pharmaceutical companies. For more information, please visit www.targacept.com.
View Top Employees from Targacept, Inc.| Website | http://www.targacept.com |
| Employees | 30 (29 on RocketReach) |
| Founded | 1997 |
| Address | 100 North Main Street Suite 1510, Winston-Salem, North Carolina 27101, US |
| Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
| Industry | Biotechnology Research |
| Web Rank | 5 Million |
| Keywords | Catalyst Biosciences News, Catalyst Biosciences Inc, Cbio, Cbio Investors, Catalyst Biosciences Announces Preclinical Proof-Of-Concept Data Of Gene Therapy Candidate Cb 2679d-Gt For The Treatment Of Hemophilia B |
Looking for a particular Targacept, Inc. employee's phone or email?
Targacept, Inc. Questions
Merouane Bencherif is the Senior Vice President of Targacept, Inc..
29 people are employed at Targacept, Inc..
Targacept, Inc. is based in Winston-Salem, North Carolina.
Top Targacept, Inc. Employees
-
35+
-
View
Balwinder Bhatti
Master scientist (Medicinal and organic chemistry) at Targacept, Inc.
Winston-Salem, NC, US12 -
11
-
14
-
11
-
23
Related Companies
